Oncology Early Phase / Multiple Disease Site Hematologic Malignancies Early Phase Team Plasma Cell Disorders Multiple Myeloma Relapsed/Refractory Exhausted all SOC options
Categories
Protocols
COMPUGEN-CPG-02-101 Phase I OPEN TO ACCRUAL
A Phase 1 Study of the Safety and Tolerability of COM902 in Subjects with Advanced Malignancies